DOXGX | TGDIX | DOXGX / TGDIX | |
Total Expense Ratio | 0.41 | 0.70 | 59% |
Annual Report Gross Expense Ratio | 0.46 | 0.77 | 60% |
Fund Existence | 3 years | 22 years | - |
Gain YTD | 6.322 | 7.138 | 89% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2000 | 125% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 117B | 464M | 25,216% |
Annual Yield % from dividends | 1.47 | 0.73 | 200% |
Returns for 1 year | 3.50 | 5.78 | 61% |
Returns for 3 years | 31.84 | 39.69 | 80% |
Returns for 5 years | N/A | 64.43 | - |
Returns for 10 years | N/A | -20.04 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ORCX | 35.99 | 2.19 | +6.48% |
Defiance Daily Target 2X Long ORCL ETF | |||
ITDB | 31.50 | 0.13 | +0.40% |
iShares LifePath Target Date 2030 ETF | |||
XBI | 88.12 | 0.30 | +0.34% |
SPDR® S&P Biotech ETF | |||
BBBS | 51.17 | 0.03 | +0.06% |
BondBloxx BBB Rated 1-5 Yr Corp Bd ETF | |||
EYLD | 36.61 | 0.01 | +0.03% |
Cambria Emerging Shareholder Yield ETF |